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Apollo 17 (1972)   

testte
Now–2024
Develop/test mitigation approaches
• ISS
• Spaceflight analogs
• Ground-based laboratories
Inform deep-space hab designs
~2022–2030
Validate mitigation approaches
• Orion
• Deep-space hab
• Lunar surface (?)
Inform exploration system designs
~2035–20nn
Fine-tune mitigation approaches
• Exploration vehicles
• Planetary surfaces
National Aeronautics and Space AdministrationHRP: Research to Enable Space Exploration
Human travelers to Mars will experience unprecedented 
physiological, environmental, and psychosocial challenges that 
could lead to significant health & performance decrements in the 
absence of effective mitigation strategies.
Success of any human mission to Mars will hinge on the mission 
designers’ ability to develop and implement such strategies.
NASA’s Human Research Program is responsible for identifying 
those strategies.
6Successes (1960-2013)
• Flyby: 7/13
• Orbiter: 12/24
• Lander: 3/11
• Rover:  4/4
• Overall: 19/44
7Radiation
Isolation/Confinement
Hostile Closed Environment
Distance from Earth
Altered Gravity Fields
8Altered Gravity Field
1. Spaceflight-Induced Intracranial Hypertension 
/ Vision Alterations
2. Renal Stone Formation 
3. Impaired Control of Spacecraft/Associated 
Systems and Decreased Mobility Due to 
Vestibular/Sensorimotor Alterations 
Associated with Space Flight
4. Bone Fracture due to spaceflight Induced 
changes to bone
5. Impaired Performance Due to Reduced 
Muscle Mass, Strength & Endurance
6. Reduced Physical Performance Capabilities 
Due to Reduced Aerobic Capacity 
7. Adverse Health Effects Due to Host-
Microorganism Interactions
8. Urinary Retention
9. Orthostatic Intolerance During Re-Exposure to 
Gravity
Concerns
1. Concern of Clinically Relevant Unpredicted 
Effects of Medication
2. Concern of Intervertebral Disc Damage upon 
and immediately after re-exposure to Gravity
Radiation
1. Risk of Space Radiation 
Exposure on Human Health
Isolation/Confinement
1. Adverse Cognitive or Behavioral 
Conditions & Psychiatric 
Disorders 
2. Performance & Behavioral 
health Decrements Due to 
Inadequate Cooperation, 
Coordination, Communication, 
& Psychosocial Adaptation 
within a Team
Hostile Closed Environment
1. Acute and Chronic Carbon Dioxide Exposure
2. Performance decrement and crew illness due 
to inadequate food and nutrition
3. Injury from Dynamic Loads
4. Injury and Compromised Performance due to 
EVA Operations
5. Adverse Health & Performance Effects of 
Celestial Dust Exposure
6. Adverse Health Event Due to Altered Immune 
Response
7. Reduced  Crew Performance Due to Hypobaric 
Hypoxia
8. Performance Decrements & Adverse Health 
Outcomes Resulting from Sleep Loss, 
Circadian Desynchronization, & Work 
Overload
9. Reduced Crew Performance Due to 
Inadequate Human-System Interaction Design 
10. Decompression Sickness
11. Toxic Exposure
12. Hearing Loss Related to Spaceflight
Distance from Earth
1. Adverse Health Outcomes & 
Decrements in Performance 
due to inflight Medical 
Conditions 
2. Ineffective or Toxic 
Medications due to Long Term 
Storage
Exploration Health & Performance Risks
NASA Human Systems Risk Board: Risks Identified for all DRMs (Jan 2015) 
HRP Integrated Path to Risk Reduction
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End ISS
Accepted Risks
Concerns
Mission Milestone
Anticipated Milestone Shift
ISS Not Required
ISS Required
Ground-based Milestones
Milestones Requires ISS ISS Mission Milestone
High LXC Mid LXC Low LXC Optimized Insufficient Data
NEK study delayed
flight queue scrub
ICC Analog access 
ExAtm validation
Pending HSRB approval
Revised delivery req’t
Unfunded task scrub
Unfunded task scrub
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ISS: Primary Space Platform for HRP Studies
 altered gravity fields (+)
 isolation/confinement (+/-)      
& altered light-dark cycles (+)
 hostile/closed environment (+)
 increased radiation (+/-)
 distance from Earth (+/-)
HRP studies receive highest priority for NASA science payloads aboard ISS.
Each USOS crewmember participates in 10-15 separate HRP experiments. 
Exploration Spaceflight Analogs
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 altered gravity fields 
 isolation/confinement 
& altered light-dark cycles
 hostile/closed environment
 increased radiation
 distance from Earth
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NASA Space Radiation Lab (NSRL) DOE/BNL
 altered gravity fields (n/a)
 isolation/confinement (n/a)        
& altered light-dark cycles (n/a)
 hostile/closed environment (n/a)
 increased radiation (+)
 distance from Earth (n/a)
• Simulates the space radiation 
environment- high energy ion 
beams  (H+, Fe, Si, C, O, Cl, Ti, 
etc.) 
• Beam line, target area, dosimetry, 
biology labs, animal care, scientific,  
logistic and administrative support
• 3 experimental campaigns per year
• Space Radiation Summer School
NSRL Beam Line
Images Courtesy of Brookhaven National Laboratory (BNL)
Altered Gravity Analogs
Head-Down-Tilt Bedrest
Parabolic Flight
 altered gravity fields (+/-)
 isolation/confinement (+/-)          
& altered light-dark cycles (+/-)
 hostile/closed environment (+/-)
 increased radiation (n/a)
 distance from Earth (n/a)
Neutral
Buoyancy
:enviHab (DLR/IAM, Cologne, Germany)
:enviHab Shake-Down Study (NSBRI)
http://www.dlr.de/me/en/desktopdefault.aspx/tabid1776/2384_read43061/ 15
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Isolated, Confined, Extreme (ICE) Analogs
 altered gravity fields (n/a)
 isolation/confinement (+)          
& altered light-dark cycles (+)
 hostile/closed environment (+/-)
 increased radiation (n/a)
 distance from Earth (+/-)
HERA:
3-4 Missions/yr
4 Crew
14, 30, 60 Days
NSF:
Multiple Stations 
winter overs+
IMBP/NEK: 
4, 8, 12 month
Human Exploration Research Analog (HERA)
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NEK (RAS/IMBP, Moscow, Russia)
Cosmonauts V.V. Polyakov and S.K. Krikalev Cosmonaut S.N. Ryazanskiy
Antarctic Stations NSF+
NSF/ South Pole Station
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Cis-Lunar Outposts: key to HRP validation
 altered gravity fields (+)
 isolation/confinement (+)        
& altered light-dark cycles (+)
 hostile/closed environment (+)
 increased radiation (+)
 distance from Earth (+)
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HRP Organization Chart
Program Clinician – Stevan Gilmore M.D.
Operations Representative – Richard M. Linnehan, DVM
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Manager –
J. Uri
Deputy Manager -
B. Mayeaux
Scientist -
L. Simonsen, Ph.D. 
Deputy Scientist -
J. Huff, Ph.D.*
Human Research Program (HRP)
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Deputy Director – Barbara J. Corbin
Chief Scientist– John B. Charles, Ph.D.
Deputy Chief Scientist – Jennifer A. Fogarty, Ph.D.
Associate Chief Scientist – Ronita L. Cromwell, Ph.D.+*
Russian Liaison – Igor Savelev, Ph.D.*
Administrative  Assistant – LaToya Eaglin*
ISS Medical Projects
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Manager –
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Deputy Manager Flight -
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*Contractor
National Space Biomedical
Research Institute (NSBRI)
Director – J. Sutton, M.D, Ph.D.
Associate Director – G. Scott, Ph.D.
Program Business Management
Bradley Stewart
ARC Project Lead
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M. Nall
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B. Higginbotham
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